New Research Poster Presentation 2.30
Metadoxine: A Novel Pharmacological Approach to Treating ADHD With Low Abuse Potential
Thursday, October 23, 2014 10:00 AM
Johanna Schumann, PhD, Alcobra Ltd., Tel Aviv, Israel
Jonathan Rubin, MD, MBA, Alcobra Inc, Tel Aviv, Israel
Yaron Daniely, MBA, PhD, Alcobra Ltd., Tel Aviv, Israel
Helen L. Rowley, PhD, RenaSci Ltd, Nottingham NG1 1GF, United Kingdom
Sharon L. Smith, PhD, RenaSci Ltd, Nottingham NG1 1GF, United Kingdom
Stephen J. Holland, BS, RenaSci Ltd, Nottingham NG1 1GF, United Kingdom
David J. Heal, PhD, RenaSci Ltd, Nottingham NG1 1GF, United Kingdom
